首页> 美国卫生研究院文献>Gut Pathogens >Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?
【2h】

Are probiotics a feasible intervention for prevention of diarrhoea in the developing world?

机译:益生菌在发展中国家预防腹泻是否可行?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

With more than 1.4 million of the 9 million child deaths being attributed to diarrhoea in 2008 and 49% of them occurring in five countries namely, India, Nigeria, Democratic Republic of the Congo, Pakistan and China, there is an urgent need for intervention to prevent and control diarrhoeal diseases. Of the various interventions, probiotics offer immense potential. The past decade has witnessed the validation of their utility for the prevention, treatment and management of a variety of infective and non infective disorders. The most investigated field continues to remain infectious diarrhoea and compelling evidence comes from randomized placebo controlled trials. While results from these studies are encouraging most of them reflect the outcomes of the developed world. Developing countries like India continue to struggle with nutritional and health challenges and bear the greatest burden of diarrhoea. A paucity of data from the developing countries limits the definite recommendation of probiotics. In these countries curd, often confused for a probiotic, is practiced as an integral part of the culture. While the nutritional benefits of these products cannot be understated, it is still uncertain whether these products can be classified as a probiotic. The emergence of probiotic foods which are scientifically validated for their efficacy and impart defined health benefits offer an excellent opportunity to improve public health. A recent randomized controlled trial conducted by the National Institute of Cholera and Enteric Diseases in Kolkata, India demonstrated a protective efficacy of 14% in preventing diarrhoea among children who received a probiotic. For the developing world however the vision for probiotics would mean a fundamental change in perception and developing a well planned strategy to allow interventions like probiotics to permeate to impoverished settings, where the assault of micro organisms is on a daily basis. This would mean that probiotics are ingrained into the public health system without being seen as a medicine.
机译:在2008年900万儿童死于腹泻的病例中,有140万人以上,其中49%发生在印度,尼日利亚,刚果民主共和国,巴基斯坦和中国五个国家,迫切需要采取干预措施预防和控制腹泻病。在各种干预措施中,益生菌具有巨大的潜力。过去十年见证了其在预防,治疗和管理各种感染性和非感染性疾病中的效用得到验证。研究最多的领域仍然是传染性腹泻,令人信服的证据来自随机安慰剂对照试验。这些研究的结果令人鼓舞,但大多数反映了发达国家的结果。像印度这样的发展中国家继续在营养和健康挑战中挣扎,腹泻负担最大。发展中国家缺乏数据限制了对益生菌的明确推荐。在这些国家中,通常将凝乳与益生菌混为一谈的凝乳被视为其文化的组成部分。虽然不能低估这些产品的营养益处,但仍不确定这些产品是否可以归类为益生菌。经科学验证其功效并赋予特定健康益处的益生菌食品的出现为改善公众健康提供了极好的机会。美国国家霍乱和肠病研究所在印度加尔各答进行的一项近期随机对照试验显示,在接受益生菌的儿童中,预防腹泻的保护率为14%。然而,对于发展中国家来说,益生菌的愿景将意味着观念上的根本改变,并制定周密的策略,以使诸如益生菌之类的干预措施渗透到贫困地区,而每天都要对微生物进行攻击。这意味着益生菌已被根深蒂固进入公共卫生系统,而没有被视为药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号